Christopher M. Yea
Overview
Christopher M. Yea received an average of $1M in total compensation, including $408K in salary, at Carbylan Therapeutics from 2018 to 2023.
2023Carbylan TherapeuticsChief Development Officer
2022Carbylan TherapeuticsChief Development Officer
2021Carbylan TherapeuticsChief Development Officer
2020Carbylan TherapeuticsChief Development Officer
2019Carbylan TherapeuticsChief Development Officer
2018Carbylan TherapeuticsChief Development Officer
Source: SEC filings on August 14, 2023 and August 25, 2020.
Related executives
We found six more executives who work or worked at Carbylan Therapeutics.
T Crockett
Carbylan Therapeutics
Chief Executive Officer
Benjamin Palleiko
Carbylan Therapeutics
Chief Financial Officer
Edward Feener
Carbylan Therapeutics
Chief Scientific Officer
David Renzi
Carbylan Therapeutics
Chief Operating Officer
Premchandran Ramiya
Carbylan Therapeutics
Vice President, Pharmaceutical Development & Supply Chain
Marcee Maroney
Carbylan Therapeutics